4Front Ventures

4Front Ventures Raises $22 Million

FFNT Profile

  • Sector: Process Industries
  • Industry: Agricultural Commodities/Milling

4Front Ventures Corp. operates as a retail and brand development company in the cannabis sector. It operates through the following divisions: Brightleaf, Mission, and Pure Ratios. The Brightleaf division oversees cultivation and manufacturing facilities in Washington, Illinois and Massachusetts. The Mission division owns, operates, and manages retail locations. The Pure Ratios division sells wellness products. The company was founded in 2011 and is headquartered in Phoenix, AZ.

Recent News

4Front Announces Fourth Quarter and Fiscal Year 2020 Results and Provides Business Update

Q4 Systemwide Pro Forma Revenue increased to $25.0 million, with full year 2020 Systemwide Pro Forma sales of $88.1 million Q4 Adjusted EBITDA increased 59% sequentially to $5.9 million, representing Adjusted EBITDA margin of 24% Reiterated FY2021 guidance for Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million The Company’s existing licensed projects at maturity represent […]

4Front Ventures Receives Approval to Begin Construction of Mission Dispensary in Brookline, Massachusetts

PHOENIX, Jan. 25, 2021 /CNW/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company“) continues to expand in the Massachusetts market and is pleased to announce that it received approval from the Brookline, Massachusetts Planning Board to start the construction of a new Mission branded dispensary. The location will initially serve adult-use customers and is on track to open […]

4Front Ventures Completes Sale-Leaseback Transaction Generating Proceeds of $33 Million

– 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”) is pleased to announce it has completed the sale and leaseback of its cultivation and production facilities in Olympia, WA and Georgetown, MA (the “Transaction”) with an affiliate of Innovative Industrial Properties, Inc., (NYSE: IIPR) (“IIP”). This previously announced Transaction generated proceeds of US$33 million which were used by […]


Something went wrong. Please refresh the page and/or try again.